应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRNS Marinus Pharmaceuticals
盘前交易 07-22 08:03:55 EDT
1.43
+0.04
+2.88%
盘前
1.38
-0.05
-3.50%
08:00 EDT
最高
1.45
最低
1.37
成交量
62.78万
今开
1.38
昨收
1.39
日振幅
5.76%
总市值
7,856万
流通市值
5,393万
总股本
5,493万
成交额
88.18万
换手率
1.66%
流通股本
3,771万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元
自选股智能写手 · 07-17
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元
自选股智能写手 · 07-16
Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元
自选股智能写手 · 07-11
Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元
自选股智能写手 · 07-10
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元
Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报1.26美元
自选股智能写手 · 07-10
Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报1.26美元
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%
自选股智能写手 · 07-08
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.13%
自选股智能写手 · 07-01
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.13%
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报1.20美元
自选股智能写手 · 06-27
Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报1.20美元
Marinus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%报1.29美元
自选股智能写手 · 06-27
Marinus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%报1.29美元
Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌5.11%报1.30美元
自选股智能写手 · 06-26
Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌5.11%报1.30美元
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.17%
自选股智能写手 · 06-19
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.17%
BUZZ-癫痫治疗未能达到后期研究的关键目标,Marinus公司业绩下滑
Reuters · 06-17
BUZZ-癫痫治疗未能达到后期研究的关键目标,Marinus公司业绩下滑
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.13%报1.48美元
自选股智能写手 · 06-13
Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.13%报1.48美元
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.26%
自选股智能写手 · 06-10
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.26%
Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%
自选股智能写手 · 06-07
Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%
Marinus Pharmaceuticals, Inc.盘中异动 急速跳水5.19%
自选股智能写手 · 05-31
Marinus Pharmaceuticals, Inc.盘中异动 急速跳水5.19%
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.27%报1.42美元
自选股智能写手 · 05-29
Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.27%报1.42美元
Marinus Pharmaceuticals, Inc.盘中异动 快速上涨5.43%报1.46美元
自选股智能写手 · 05-28
Marinus Pharmaceuticals, Inc.盘中异动 快速上涨5.43%报1.46美元
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报1.37美元
自选股智能写手 · 05-25
Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报1.37美元
Marinus Pharmaceuticals, Inc.2024财年第一财季实现净利润-38.67百万美元,同比减少11.34%
自选股智能写手 · 05-17
Marinus Pharmaceuticals, Inc.2024财年第一财季实现净利润-38.67百万美元,同比减少11.34%
加载更多
公司概况
公司名称:
Marinus Pharmaceuticals
所属市场:
NASDAQ
上市日期:
--
主营业务:
Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司,专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子,它是异孕烯醇的合成类似物,异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体,调节大脑神经递质γ-氨基丁酸(GABA)。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法,用于治疗成人癫痫患者部分发作(也称为局灶性发作)。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验,表明与添加安慰剂的患者相比,在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验,该公司打算扩大该试验,以便在向美国食品和药物管理局(FDA)或欧洲药品管理局(EMA)提交的关于加那索龙治疗癫痫的注册文件中,作为其充分且受控的临床试验之一。
发行价格:
--
{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":1.43,"timestamp":1721419200000,"preClose":1.39,"halted":0,"volume":627825,"hourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.43,"latestTime":"08:00 EDT","volume":19,"amount":26.22,"timestamp":1721649600467},"delay":0,"floatShares":37714952,"shares":54933774,"eps":-2.642427,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.04,"latestTime":"07-22 08:03:55 EDT","open":1.38,"high":1.445,"low":1.365,"amount":881811.0387075001,"amplitude":0.057554,"askPrice":1.5,"askSize":8400,"bidPrice":1.27,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.642427,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1406779200000,"adjPreClose":1.43,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.38,"preClose":1.43,"latestTime":"08:00 EDT","volume":19,"amount":26.22,"timestamp":1721649600467},"postHourTrading":{"tag":"盘后","latestPrice":1.4,"preClose":1.43,"latestTime":"19:38 EDT","volume":1051,"amount":1463.4355,"timestamp":1721432316026},"volumeRatio":0.721100338200128,"impliedVol":3.734,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2452169105","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.42%报1.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452169105","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452169105?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:35","pubTimestamp":1721230523,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时35分,Marinus Pharmaceuticals, Inc.股票出现波动,股价快速下跌5.42%。截至发稿,该股报1.40美元/股,成交量15.9355万股,换手率0.29%,振幅4.75%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为2.04%。其相关个股中,Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃,换手率分别为3038.95%、1326.43%、280.07%,振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为76.39%、46.25%、43.75%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172335239681db4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172335239681db4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2451919144","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.67%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451919144","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451919144?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:11","pubTimestamp":1721142704,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时11分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.67%。截至发稿,该股报1.49美元/股,成交量20.3429万股,换手率0.37%,振幅4.96%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Silo Pharma, Inc.、Virpax Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.涨幅较大,Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2616.56%、1223.73%、355.64%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Virpax Pharmaceuticals, Inc.、Silo Pharma, Inc.,振幅分别为79.41%、61.68%、57.94%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144941f7793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231144941f7793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2450366326","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅上涨5.69%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450366326","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450366326?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:01","pubTimestamp":1720706499,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时01分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.69%。截至发稿,该股报1.30美元/股,成交量3.2799万股,换手率0.06%,振幅4.07%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.84%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大,Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Salarius Pharmaceuticals, Inc.较为活跃,换手率分别为496.11%、368.68%、274.42%,振幅较大的相关个股有Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc,振幅分别为149.00%、82.31%、73.13%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220139af91debe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220139af91debe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2450815452","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.60%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450815452","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450815452?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:55","pubTimestamp":1720619748,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日21时55分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.60%。截至发稿,该股报1.32美元/股,成交量4.7256万股,换手率0.09%,振幅4.80%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.35%。其相关个股中,Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃,换手率分别为2019.31%、943.95%、581.00%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.,振幅分别为119.83%、62.50%、59.23%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102155499681b8d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102155499681b8d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2450667078","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450667078","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450667078?lang=zh_cn&edition=full","pubTime":"2024-07-10 00:45","pubTimestamp":1720543517,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日00时45分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.00%。截至发稿,该股报1.26美元/股,成交量25.2609万股,换手率0.46%,振幅4.58%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.27%。其相关个股中,Soligenix, Inc.、180 Life Sciences Corp.、Uniqure N.V.涨幅较大,Soligenix, Inc.、180 Life Sciences Corp.、Longeveron Inc.较为活跃,换手率分别为10176.28%、2515.92%、330.64%,振幅较大的相关个股有Soligenix, Inc.、180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为327.50%、196.29%、134.00%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710004517aef8c0a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710004517aef8c0a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2449704161","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449704161","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449704161?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:56","pubTimestamp":1720450618,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时56分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.00%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.97%。其相关个股中,Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Morphic Holding, Inc.涨幅较大,Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃,换手率分别为3064.03%、175.98%、141.60%,振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Fortress Biotech Inc 9.375% Cum Red Per Pref Ser A Usd25.00、Cero Therapeutics Holdings, Inc.,振幅分别为121.11%、46.35%、36.60%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708225659af911930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708225659af911930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2448911670","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448911670","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448911670?lang=zh_cn&edition=full","pubTime":"2024-07-01 22:23","pubTimestamp":1719843824,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日22时23分,Marinus Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.13%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.83%。其相关个股中,Senti Biosciences, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为388.24%、123.31%、91.56%,振幅较大的相关个股有Senti Biosciences, Inc.、Seastar Medical Holding Corporation、Humacyte Inc C/Wts 27/08/2026 ,振幅分别为101.49%、31.27%、28.78%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务,即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701222344941f2c31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701222344941f2c31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2446553645","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.16%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446553645","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446553645?lang=zh_cn&edition=full","pubTime":"2024-06-27 21:39","pubTimestamp":1719495580,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日21时39分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.16%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.09%。其相关个股中,Nls Pharmaceutics Ltd.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Nls Pharmaceutics Ltd.、Kala Bio, Inc.、Gri Bio, Inc.较为活跃,换手率分别为187.67%、101.72%、100.94%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Nls Pharmaceutics Ltd.、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为66.67%、60.13%、49.62%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721394096817835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062721394096817835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2446316684","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速跳水5.15%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446316684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446316684?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:52","pubTimestamp":1719420730,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时52分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.15%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,Anew Medical, Inc.、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 、Diamedica Therapeutics Inc.涨幅较大,Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃,换手率分别为682.49%、155.51%、111.10%,振幅较大的相关个股有Anew Medical, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ,振幅分别为112.12%、51.85%、45.14%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005210af8f5b69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627005210af8f5b69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2446582131","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌5.11%报1.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582131","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446582131?lang=zh_cn&edition=full","pubTime":"2024-06-26 00:47","pubTimestamp":1719334078,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日00时47分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速下挫5.11%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.55%。其相关个股中,Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大,Cns Pharmaceuticals, Inc.、Effector Therapeutics, Inc.、Glycomimetics, Inc.较为活跃,换手率分别为855.15%、225.15%、175.26%,振幅较大的相关个股有Effector Therapeutics Inc C/Wts 31/12/2025 、Cns Pharmaceuticals, Inc.、Glycomimetics, Inc.,振幅分别为272.73%、77.13%、47.00%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062600475996816ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062600475996816ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2444524104","title":"Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444524104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444524104?lang=zh_cn&edition=full","pubTime":"2024-06-19 02:58","pubTimestamp":1718737133,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日02时58分,Marinus Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.17%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。消息层面,截至02时58分,《JMP Securities维持Marinus Pharmaceuticals买入评级,维持目标价10美元》资讯为影响Marinus Pharmaceuticals, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025854af8e16f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025854af8e16f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2444163030","title":"BUZZ-癫痫治疗未能达到后期研究的关键目标,Marinus公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2444163030","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444163030?lang=zh_cn&edition=full","pubTime":"2024-06-17 19:32","pubTimestamp":1718623932,"startTime":"0","endTime":"0","summary":" 6月17日 - ** 制药商Marinus Pharmaceuticals 股价盘前下跌12.6%,报1.30美元。** 该公司称 ,在一项后期研究中,该公司针对一种被称为难治性癫痫状态的癫痫发作的静脉注射疗法未能达到两个关键目标之一。** Miranus公司的药物ganaxolone与安慰剂相比,在第二个终点--不进行静脉麻醉的患者比例--上未能达到统计学意义。** 该药的口服版本已获美国 FDA 批准,用于治疗与 CDKL5 缺乏症相关的癫痫发作。** 截至上次收盘,股价累计下跌 86.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS","BK4007","BUZZ"],"gpt_icon":0},{"id":"2443591568","title":"Marinus Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443591568","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443591568?lang=zh_cn&edition=full","pubTime":"2024-06-13 03:28","pubTimestamp":1718220510,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日03时28分,Marinus Pharmaceuticals, Inc.股票出现波动,股价快速下挫5.13%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.65%。其相关个股中,Cingulate Inc C/Wts 10/12/2026 、Longeveron Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Longeveron Inc.、Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.较为活跃,换手率分别为902.78%、156.00%、39.12%,振幅较大的相关个股有Longeveron Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为120.84%、85.53%、76.92%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061303283196813c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061303283196813c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2442826351","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442826351","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442826351?lang=zh_cn&edition=full","pubTime":"2024-06-10 23:58","pubTimestamp":1718035102,"startTime":"0","endTime":"0","summary":"北京时间2024年06月10日23时58分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速拉升5.26%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.10%。其相关个股中,Surrozen Inc C/Wts 01/08/2031 、Clene Inc C/Wts 30/12/2025 、Renovaro Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.、Hoth Therapeutics, Inc.较为活跃,换手率分别为50.73%、42.27%、39.84%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Dermata Therapeutics Inc C/Wts ,振幅分别为142.25%、134.12%、107.32%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务,即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610235822941ed711&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240610235822941ed711&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2441062486","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441062486","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441062486?lang=zh_cn&edition=full","pubTime":"2024-06-07 22:39","pubTimestamp":1717771153,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日22时39分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅拉升5.00%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.29%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nutriband Inc C/Wts 、Vigil Neuroscience, Inc.涨幅较大,Biocardia, Inc.、Scinai Immunotherapeutics Ltd、Virax Biolabs Group Limited较为活跃,换手率分别为344.45%、106.46%、46.41%,振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为65.57%、62.99%、44.19%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607223913af8cab91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607223913af8cab91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2439677854","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439677854","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439677854?lang=zh_cn&edition=full","pubTime":"2024-05-31 03:57","pubTimestamp":1717099058,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日03时57分,Marinus Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.19%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。其相关个股中,Summit Therapeutics Inc.、Humacyte Inc C/Wts 27/08/2026 、Clene Inc C/Wts 30/12/2025 涨幅较大,Kintara Therapeutics, Inc.、Mustang Bio, Inc.、Onconetix, Inc.较为活跃,换手率分别为138.17%、77.05%、69.03%,振幅较大的相关个股有Summit Therapeutics Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Calidi Biotherapeutics, Inc.,振幅分别为293.36%、104.00%、93.84%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531035738aef29569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531035738aef29569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2439052093","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.27%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439052093","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439052093?lang=zh_cn&edition=full","pubTime":"2024-05-29 21:36","pubTimestamp":1716989766,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日21时36分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速跳水5.27%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.43%。其相关个股中,Tc Biopharm Plc C/Wts 10/02/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Celularity Inc C/Wts 16/07/2026 涨幅较大,Mustang Bio, Inc.、Scorpius Holdings, Inc.、Transcode Therapeutics, Inc.较为活跃,换手率分别为89.36%、69.29%、9.40%,振幅较大的相关个股有Tc Biopharm Plc C/Wts 10/02/2028 、Scorpius Holdings, Inc.、Calidi Biotherapeutics, Inc.,振幅分别为91.00%、17.16%、9.92%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529213606aef255ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529213606aef255ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2438360370","title":"Marinus Pharmaceuticals, Inc.盘中异动 快速上涨5.43%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438360370","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438360370?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:56","pubTimestamp":1716904560,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时56分,Marinus Pharmaceuticals, Inc.股票出现异动,股价快速上涨5.43%。截至发稿,该股报1.46美元/股,成交量8.9041万股,换手率0.16%,振幅4.71%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.55%。其相关个股中,Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大,Exicure, Inc.、Mustang Bio, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为48.99%、11.21%、10.88%,振幅较大的相关个股有Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Renovaro Inc.,振幅分别为70.52%、20.73%、20.42%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528215601aef21b67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240528215601aef21b67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2438068852","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.00%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2438068852","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438068852?lang=zh_cn&edition=full","pubTime":"2024-05-25 00:44","pubTimestamp":1716569049,"startTime":"0","endTime":"0","summary":"北京时间2024年05月25日00时44分,Marinus Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.00%。截至发稿,该股报1.37美元/股,成交量45.0685万股,换手率0.82%,振幅5.78%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.99%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Merus N.V.涨幅较大,Onconetix, Inc.、Verastem, Inc.、Altamira Therapeutics Ltd.较为活跃,换手率分别为137.26%、52.94%、33.53%,振幅较大的相关个股有Onconetix, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cns Pharmaceuticals, Inc.,振幅分别为104.53%、57.38%、52.04%。Marinus Pharmaceuticals, Inc.公司简介:Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250044099680fa97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250044099680fa97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2436075826","title":"Marinus Pharmaceuticals, Inc.2024财年第一财季实现净利润-38.67百万美元,同比减少11.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436075826","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436075826?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:22","pubTimestamp":1715876562,"startTime":"0","endTime":"0","summary":"3月31日,Marinus Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第一财季净利润为-38.67百万美元,同比减少11.34%;其中营业收入为7.68百万美元,同比减少26.01%,每股基本收益为-0.68美元。机构评级:截至2024年3月31日,当前有9家机构对Marinus Pharmaceuticals, Inc.目标价做出预测,其中目标均价为6.67美元,其中最低目标价为2.00美元,最高目标价为13.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700225287713941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051700225287713941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":0.0251},{"period":"3month","weight":0.0362},{"period":"6month","weight":-0.8512},{"period":"1year","weight":-0.8558},{"period":"ytd","weight":-0.8684}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司,专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子,它是异孕烯醇的合成类似物,异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体,调节大脑神经递质γ-氨基丁酸(GABA)。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法,用于治疗成人癫痫患者部分发作(也称为局灶性发作)。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验,表明与添加安慰剂的患者相比,在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验,该公司打算扩大该试验,以便在向美国食品和药物管理局(FDA)或欧洲药品管理局(EMA)提交的关于加那索龙治疗癫痫的注册文件中,作为其充分且受控的临床试验之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037828},{"month":2,"riseRate":0.6,"avgChangeRate":-0.012045},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007141},{"month":6,"riseRate":0.5,"avgChangeRate":0.034813},{"month":7,"riseRate":0.6,"avgChangeRate":0.024682},{"month":8,"riseRate":0.5,"avgChangeRate":0.032608},{"month":9,"riseRate":0.6,"avgChangeRate":0.189829},{"month":10,"riseRate":0.3,"avgChangeRate":-0.14351},{"month":11,"riseRate":0.4,"avgChangeRate":0.025431},{"month":12,"riseRate":0.6,"avgChangeRate":0.123461}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}